Article
Prognostic and therapeutic value of a 23-gene risk score tailored to the molecular characteristics of mucinous colorectal cancer.
British journal of cancer - 1 Sept 2025
Seo Jee-Woo, Kim Jae-Yoon, Ha Ye Jin, Tak Ka Hee, Kim Jeong-Hwan, Cho Young-Bum, Park Seong-Hwan, Yoon Yong Sik, Kim Chan Wook, Lee Jong Lyul, Kim Seon-Young, Kim Seon-Kyu
Abstract excerpt
BACKGROUND: Mucinous adenocarcinoma (MuC), a colorectal cancer (CRC) subtype, exhibits distinct molecular features and poorer response to chemoradiotherapy than non-mucinous adenocarcinoma (NMuC). Conventional treatments often fail to address CRC heterogeneity, particularly in stage II disease. Therefore, improved biomarkers for risk stratification and personalised treatment are needed. METHODS: We analysed gene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
